do glp 1 cause heart problems The Cardiovascular Biology of Glucagon-like Peptide-1 Glucagon-Like Peptide-1 Agonist Use in

Diabetes Care 2005

N Engl J Med 360:129139 The ADVANCE Collaborative Group (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

The strongest GLP-1 plan is not the most uncomfortable plan

Comparable to other peptides linked to fatty acids (e.g., the insulins detemir and degludec, the GLP-1RA liraglutide and semaglutide), the fatty acid side chain allows binding to albumin after subcutaneous injection, slows enzymatic degradation and prolongs biological half-life (5760)

The GLP-1 that does reach the pancreas calls for the release of more insulin when food is being broken down and absorbed

The Emerging Role of Polyphenols in the Management of Type 2 Diabetes